GSK plc Reports Share Transaction

TL;DR

GSK bought back its own shares in Sept 2025.

AI Summary

GSK plc announced on September 10, 2025, that it has completed a transaction involving its own shares. The filing, a Form 6-K, details this activity for the month of September 2025. GSK plc is a pharmaceutical preparations company based in London.

Why It Matters

This filing indicates GSK plc is actively managing its share capital, which can impact shareholder value and company financial metrics.

Risk Assessment

Risk Level: low — The filing reports a routine transaction in the company's own shares, which is common for publicly traded companies and does not inherently signal significant risk.

Key Players & Entities

• GSK plc (company) — Registrant and subject of the filing
• 001-15170 (company) — SEC file number for GSK plc
• 79 New Oxford Street, London, WC1A 1DG (company) — Principal executive office address of GSK plc
• September 2025 (date) — Reporting period for the transaction

FAQ

Filing Documents

• a6743y.htm (6-K) — 1420KB
• 0001654954-25-010565.txt ( ) — 1421KB

From the Filing

IN OWN SHARES a6743y   UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   Form 6-K   REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934       For the month of September 2025   Commission File Number 001-15170     GSK plc (Translation of registrant's name into English)     79 New Oxford Street, London, WC1A 1DG (Address of principal executive office)       Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.   Form 20-F . . . .X. . . . Form 40-F . . . . . . . .                                       Transaction in own shares   GSK plc (the " Company ") announces today   acting through its corporate stockbroker, Merrill Lynch International (the " Broker "), it has purchased the following number of the Company's ordinary shares of  31¼  pence each.       Date of purchase:   09 September 2025   Aggregate number of ordinary shares of  31¼  pence each purchased:   207,767   Lowest price paid per share (GBp):   1,468.50p   Highest price paid per share (GBp):   1,490.50p   Volume-weighted average price paid per share (GBp):   1,483.93p     The purchased shares will be held as Treasury shares.   Such purchase forms part of the Company's existing buyback programme and was effected pursuant to the non-discretionary agreement entered into with the Broker on 4 June 2025, as announced on 4 June 2025. Since 4 June 2025 the Company has purchased 28,019,060 ordinary shares.   Following the above purchase, the Company will hold 246,153,443 ordinary shares in treasury and have 4,069,248,284 ordinary shares in issue (excluding Treasury shares).   The total number of voting rights in the Company is   4,069,248,284. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.   The Company confirms that, in accordance with DTR 5.5.1R, following the above purchase the percentage of voting rights attributable to the ordinary shares held in treasury is   6.05 per cent.   The table below contains detailed information of the individual trades made by the Broker on the London Stock Exchange and the CBOE Europe Limited recognised investment exchange (through its order books having market identification codes CHIX or BATE) as part of the buyback programme.     Schedule of Purchases   Shares purchased:      GSK plc (ISIN: GB00BN7SWP63)   Date of purchases:     09 September 2025   Investment firm:        Merrill Lynch International     Aggregated information per trading venue:   Venue   Number of ordinary shares purchased   Highest price paid (per ordinary share) (GBp)   Lowest price paid (per ordinary share) (GBp)   Volume weighted average price paid (per ordinary share) (GBp)   London Stock Exchange (XLON)   207,767   1,490.50p   1,468.50p   1,483.93p   CBOE (CHIX)   0   -   -   -   CBOE (BATE)   0   -   -   -       Individual transactions:   Number ofShares   Price per Share (GBp)   Tradingvenue   Date oftransaction   Time oftransaction   Transaction reference number   31   1,471.00    XLON   09-Sep-2025   08:00:05   0XL06400000000005MJ96N   31   1,471.00    XLON   09-Sep-2025   08:00:05   0XL06400000000005MJ96O   32   1,470.50    XLON   09-Sep-2025   08:00:05   0XL06A00000000005MJ96K   32   1,471.00    XLON   09-Sep-2025   08:00:05   0XL06700000000005MJ96A   57   1,469.50    XLON   09-Sep-2025   08:00:05   0XL06A00000000005MJ96O   58   1,470.00    XLON   09-Sep-2025   08:00:05   0XL06400000000005MJ96Q   62 &#xA

View Full Filing

View this 6-K filing on SEC EDGAR